5Michallet M, Sobh M, E1-Cheikh J, et al. Evolving strategies with immunomodulating drugs and tandem autologous/allogeneic hematopoietic stem cell transplantation in first line high risk multiple myeloma patients. Exp Hematol, 2013, 41 (12) : 1008-1015.
6Price SD, Holman CD, Sanfilippo FM, et al. Impact of specific Beers Criteria medications on associations between drug exposure and unplanned hospitalisation in elderly patients taking high-risk drugs: a case- time-control study in Western Australia. Drugs Aging, 2014, 31 (4) : 311- 325.
7Mackiewiez A, Maekiewicz J, Wysocki PJ, et al. Long-term survival of high-risk melanoma patients immunized with a Hyper-IL-6-modified allogeneic whole-cell vaccine after complete resection. Expert Opin Investig Drugs, 2012, 21 (6) : 773-783.
